drugset / Trial / NCT03807856

Treating Acute Pancreatitis With Dabigatran, a Pilot Study

NCT03807856

Phase 1 Terminated 2 enrolled Mayo Clinic
RandomizedParallel-groupOpen-labelTreatment

Summary

Researchers are studying the safety and efficacy of Dabigatran in the treatment of acute pancreatitis.

Timeline

Start
2019-06-24
Primary completion
2020-07-23
Completion
2020-07-23

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dabigatran etexilate Unknown 150 mg

Indications